Boehringer Ingelheim and 3T Biosciences to develop next-generation cancer immunotherapies
Boehringer Ingelheim and 3T Biosciences have entered into a strategic collaboration and licensing agreement to…
January 9, 2023 - 2 minutes
Boehringer Ingelheim and 3T Biosciences have entered into a strategic collaboration and licensing agreement to…